These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 6188940
21. [Diagnostic progress in testicular carcinoma]. Aiginger P, Kolbe H, Kühböck J, Spona J. Acta Med Austriaca; 1978; 5(4-5):159-61. PubMed ID: 91300 [Abstract] [Full Text] [Related]
22. [Biological markers in cancer of the testis]. Lotsberg J, Fosså SD, Klepp O, Orjasaeter H, Torjesen PA. Tidsskr Nor Laegeforen; 1980 Apr 30; 100(12):688-90. PubMed ID: 6158120 [No Abstract] [Full Text] [Related]
30. [Tumor markers in germ cell tumors. Clinical use and research aspects]. Clausen PP, Nørgaard-Pedersen B, Arends J, Ingild A, Jacobsen GK, Jacobsen M, Juhl BR, Kjaersgaard E, Nissen MH, Schultz-Larsen P, Toftager-Larsen K, Zeuthen J. Ugeskr Laeger; 1982 May 03; 144(18):1285-90. PubMed ID: 6181594 [No Abstract] [Full Text] [Related]
31. Re: alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors. Javadpour N. J Urol; 1978 Mar 03; 119(3):422-3. PubMed ID: 76688 [No Abstract] [Full Text] [Related]
32. [Germ cell testicular tumors. Three therapeutic periods]. Fargeot P. Bull Cancer; 1990 Mar 03; 77(4):331-9. PubMed ID: 1693863 [Abstract] [Full Text] [Related]
33. Pre-, per- and post-chemotherapy tumour markers in very advanced testicular cancer. Fossa SD, Paus E. Prog Clin Biol Res; 1985 Mar 03; 203():121. PubMed ID: 2421325 [No Abstract] [Full Text] [Related]
34. Serum markers in testicular tumors. Narayana AS, Loening S, Weimar G, Culp DA. J Urol; 1979 Jan 03; 121(1):51-3. PubMed ID: 83396 [Abstract] [Full Text] [Related]
35. [Tumor markers as a prognostic factor of the response to treatment in cancer of the testicle]. Germa Lluch JR, Bastus Piulats R. Actas Urol Esp; 1987 Jan 03; 11(3):293-8. PubMed ID: 2444075 [No Abstract] [Full Text] [Related]
36. [Alpha-fetoprotein and chorionic gonadotropin in seminoma of the testis]. Sakalo VS, Romanenko AM, Persidskiĭ IuV, Iugrinova LG. Urol Nefrol (Mosk); 1988 Jan 03; (2):46-50. PubMed ID: 2455374 [No Abstract] [Full Text] [Related]
37. Re: Determination of pre-orchiectomy serum levels of alpha-fetoprotein and human choriogonadotrophin in testicular cancer. Sophie D. Fosså and M. Mason. Br. J. Urol., 69, 108, 1992. Harland SJ. Br J Urol; 1992 Jun 03; 69(6):669. PubMed ID: 1379103 [No Abstract] [Full Text] [Related]
38. Serum alpha-fetoprotein and beta-human chorionic gonadotropin levels in patients with non-seminomatous germ cell testicular cancer. Lange PH, Hakala TR, Fraley EE. Minn Med; 1975 Nov 03; 58(11):813-5. PubMed ID: 53783 [No Abstract] [Full Text] [Related]
39. [Tumor marker in urology]. Shimazaki J, Ito H, Miyauchi T, Maruoka M, Isaka S, Masukagami T, Ando K. Gan No Rinsho; 1983 May 03; 29(6):684-92. PubMed ID: 6192269 [Abstract] [Full Text] [Related]
40. Significance of elevated serum alphafetoprotein (AFP) in seminoma. Javadpour N. Cancer; 1980 Apr 15; 45(8):2166-8. PubMed ID: 6154525 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]